State Street’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,733,674
Closed -$62.4M 4886
2022
Q4
$62.4M Sell
3,733,674
-50,370
-1% -$851K ﹤0.01% 1478
2022
Q3
$64.9M Buy
3,784,044
+98,102
+3% +$1.54M ﹤0.01% 1411
2022
Q2
$28.9M Buy
3,685,942
+964,549
+35% +$8.29M ﹤0.01% 1980
2022
Q1
$30.2M Buy
2,721,393
+210,424
+8% +$2.36M ﹤0.01% 2103
2021
Q4
$44.1M Buy
2,510,969
+248,538
+11% +$4.82M ﹤0.01% 1898
2021
Q3
$45.8M Buy
2,262,431
+117,142
+5% +$3.01M ﹤0.01% 1871
2021
Q2
$70.9M Buy
2,145,289
+611,868
+40% +$23.1M ﹤0.01% 1580
2021
Q1
$59.9M Buy
1,533,421
+12,079
+0.8% +$567K ﹤0.01% 1608
2020
Q4
$66.4M Buy
1,521,342
+130,645
+9% +$4.46M ﹤0.01% 1459
2020
Q3
$39.4M Buy
1,390,697
+985,523
+243% +$31.1M ﹤0.01% 1621
2020
Q2
$14.7M Buy
405,174
+91,741
+29% +$2.58M ﹤0.01% 2200
2020
Q1
$5.69M Buy
+313,433
New +$6.87M ﹤0.01% 2564

State Street's ONEM Position: Q1 2023 in Review

State Street sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 3,733,674 shares — an estimated $62.4M sold.

State Street first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $70.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • State Street reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • State Street sold 3,733,674 1Life Healthcare shares in Q1 2023, an estimated $62.4M.
  • State Street first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • State Street's 1Life Healthcare position peaked at $70.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.